Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Psyence Biomedical Ltd. PBM

Full chart Compare
Set alert

Price alert · PBM

All alert types
3.18 USD -0.11 (-3.34%)

At closeNov 4, 2026, 4:50 PM EST

3.18 0.00 +0.08%

After hours · Nov 4, 4:50 PM ET

3.10 Day range 3.44
1.92 52-week range 116.41
YTD
-89.19%
1 year
-97.03%

Financial health

Altman Z-Score

-6.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2020: 0.0×FY 2021: 111853×FY 2022: -47230×FY 2023: -457×FY 2024: 14.2×FY 2025: -0.2×
FY 2020 5y median -0.2× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 0.1×
FY 2020: 0.0×FY 2021: 3861×FY 2022: 4037×FY 2023: -2133×FY 2024: 2.1×FY 2025: 0.1×
FY 2020 5y median 2.1× FY 2025
P/FCF -0.2×
FY 2020: 0.0×FY 2021: -1088806×FY 2022: -1900823×FY 2023: -7930×FY 2024: -3.8×FY 2025: -0.2×
FY 2020 5y median -7930× FY 2025
EV/EBITDA 0.9×
FY 2020: 0.0×FY 2021: 86371×FY 2022: 91720×FY 2023: -458×FY 2024: 8.0×FY 2025: 0.9×
FY 2020 5y median 8.0× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -636.2%
FY 2020: 0.0%FY 2021: -0.0%FY 2022: -0.0%FY 2023: -0.0%FY 2024: -26.2%FY 2025: -636.2%
FY 2020 5y median -0.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -40.9%
FY 2020: 0.0%FY 2021: 3.5%FY 2022: 3.3%FY 2023: 466.2%FY 2024: 15.1%FY 2025: -40.9%
FY 2020 5y median 3.5% FY 2025
ROIC -36.8%
FY 2020: 0.0%FY 2021: -0.1%FY 2022: -1.8%FY 2023: 524.5%FY 2024: -54.5%FY 2025: -36.8%
FY 2020 5y median -1.8% FY 2025
ROA -39.5%
FY 2020: 0.0%FY 2021: 2.5%FY 2022: 3.1%FY 2023: -4518.7%FY 2024: 13.8%FY 2025: -39.5%
FY 2020 5y median 2.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income -70.3%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -1208.8%FY 2023: 37.1%FY 2024: -33.1%FY 2025: -70.3%
FY 2020 FY 2025
EPS (diluted) -805.6%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -356.0%FY 2023: -1126.6%FY 2024: 122.7%FY 2025: -805.6%
FY 2020 FY 2025
Free Cash Flow -130.8%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 38.1%FY 2023: -468.0%FY 2024: -26.9%FY 2025: -130.8%
FY 2020 FY 2025

Financial Health

Current Ratio 14.6×
FY 2020: 48.5×FY 2021: 5.6×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 11.0×FY 2025: 14.6×
FY 2020 5y median 5.6× FY 2025
Quick Ratio 14.6×
FY 2020: 48.5×FY 2021: 5.9×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 11.0×FY 2025: 14.6×
FY 2020 5y median 5.9× FY 2025
Debt / Equity 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -1.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2020: 0.0×FY 2021: -0.0×FY 2022: 0.1×FY 2023: -0.2×FY 2024: -6.0×FY 2025: 1.1×
FY 2020 5y median -0.0× FY 2025
Interest Coverage -655×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -52.0×FY 2024: -395×FY 2025: -655×
FY 2020 5y median -52.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2026-03-31